Llwytho...
PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model
Immune checkpoint inhibition used in combination with standard cisplatin-based chemotherapy regimens is currently under evaluation in clinical trials for head and neck squamous cell carcinoma (HNSCC). The impact of anti–PD-1 therapy on cisplatin-induced ototoxicity and nephrotoxicity has not been es...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Otolaryngol Head Neck Surg |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134261/ https://ncbi.nlm.nih.gov/pubmed/29609517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0194599818767621 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|